ArticleWorld journal of gastroenterology2011
Risk factors for hilar cholangiocarcinoma: a case-control study in China.
Article in World journal of gastroenterology, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers, 6 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
18 citing papers in PubMed, 6 syntheses or guidelines pooled it, 43 citations in OpenAlex.
- Association between gallstones and the risk of biliary tract cancer: a systematic review and meta-analysis.Epidemiology and health · 2021Pooled it
- Viral hepatitis B and C infections increase the risks of intrahepatic and extrahepatic cholangiocarcinoma: Evidence from a systematic review and meta-analysis.The Turkish journal of gastroenterology : the official journal of Turkish Society of Gastroenterology · 2020Pooled it
- HBV Infection Status and the Risk of Cholangiocarcinoma in Asia: A Meta-Analysis.BioMed research international · 2016Pooled it
- Hepatitis C virus infection and the risk of intrahepatic cholangiocarcinoma and extrahepatic cholangiocarcinoma: evidence from a systematic review and meta-analysis of 16 case-control studies.World journal of surgical oncology · 2015Pooled it
- Association between Liver Fluke Infection and Hepatobiliary Pathological Changes: A Systematic Review and Meta-Analysis.PloS one · 2015Pooled it
- Smoking, alcohol consumption, and the risk of extrahepatic cholangiocarcinoma: a meta-analysis.World journal of gastroenterology · 2013Pooled it
- The Role of microRNAs in Cholangiocarcinoma.International journal of molecular sciences · 2021Review
- Complete laparoscopic radical resection of hilar cholangiocarcinoma: technical aspects and long-term results from a single center.Wideochirurgia i inne techniki maloinwazyjne = Videosurgery and other miniinvasive techniques · 2021Article
- Effect of vascular resection for perihilar cholangiocarcinoma: a systematic review and meta-analysis.PeerJ · 2021Article
- Alcoholic liver disease and risk of cholangiocarcinoma: a systematic review and meta-analysis.OncoTargets and therapy · 2018Article
- Article
- Systematic review and meta-analysis: cholecystectomy and the risk of cholangiocarcinoma.Oncotarget · 2017Article
- Serum albumin predicts survival in patients with hilar cholangiocarcinoma.Gastroenterology report · 2017Article
- Hepatitis B virus infection, diabetes mellitus, and their synergism for cholangiocarcinoma development: a case-control study in Korea.World journal of gastroenterology · 2015Article
- Diabetes mellitus and the risk of cholangiocarcinoma: an updated meta-analysis.Przeglad gastroenterologiczny · 2015Article
- Hilar cholangiocarcinoma: diagnosis, treatment options, and management.Hepatobiliary surgery and nutrition · 2014Review
- Medical risk factors associated with cholangiocarcinoma in Taiwan: a population-based case-control study.PloS one · 2013Article
- The global epidemiology of clonorchiasis and its relation with cholangiocarcinoma.Infectious diseases of poverty · 2012Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
aimTo study the association between hilar cholangiocarcinoma (HC) and pre-existing medical conditions.
methodsThree hundred and thirteen HC patients admitted to the Eastern Hepatobiliary Surgery Hospital (Shanghai, China) in 2000-2005 and 608 healthy controls were enrolled in this study. Association between HC and pre-existing medical conditions was studied with their adjusted odds ratio (OR) calculated by logistic regression analysis.
resultsThe prevalence of choledocholithiasis (adjusted OR = 2.704, P = 0.039), hepatolithiasis (adjusted OR = 3.278, P = 0.018), cholecystolithiasis (adjusted OR = 4.499, P < 0.0001), cholecystectomy (adjusted OR = 7.012, P = 0.004), biliary ascariasis (adjusted OR = 7.188, P = 0.001), liver fluke (adjusted OR = 10.088, P = 0.042) and liver schistosomiasis (adjusted OR = 9.913, P = 0.001) was higher in HC patients than in healthy controls.
conclusionBiliary tract stone disease (choledocholithiasis, hepatolithiasis, cholecystolithiasis) and parasitic liver disease (biliary ascariasis, liver fluke, liver schistosomiasis) are the risk factors for HC in Chinese population.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.